Panchgar Vinayak, Shetti Akshaya N, Sunitha H B, Dhulkhed Vithal K, Nadkarni A V
Department of Anesthesiology and Critical Care, Gadag Medical College, Gadag, Karnataka, India.
Department of Anesthesiology and Critical Care, Rural Medical College, Pravara Institute of Medical Sciences, Loni (Bk), Ahmednagar, Maharashtra, India.
Anesth Essays Res. 2017 Jan-Mar;11(1):72-77. doi: 10.4103/0259-1162.200232.
There is an upward surge in the use of laparoscopic surgeries due to various advantages when compared to open surgeries. Major advantages are, due to small incisions which are cosmetically acceptable and most of them are now daycare procedures. Problem of economic burden and hospital bed occupancy has been overcome with laparoscopic surgeries. All these advantages are not free from disadvantages, as hemodynamic changes such as hypertension; tachycardia and other surgical-related complications are commonly observed intraoperatively. Dexmedetomidine is one of the α agonist drugs which acts at both supraspinal and spinal level and modulate the transmission of nociceptive signals in the central nervous system. The basic effect of dexmedetomidine on the cardiovascular system is to decrease the heart rate and systemic vascular resistance with additional feature of opioid sparing effect. This drug has become an ideal adjuvant during general anesthesia, especially when stress is expected. Hence, the drug was studied in laparoscopic surgeries.
(a) To study the effect of dexmedetomidine on hemodynamic parameters during perioperative period in patients undergoing laparoscopic surgery. (b) To study the postoperative sedation score and analgesic requirement. (c) To study the side effect profile of dexmedetomidine.
Randomized double blind controlled trial.
After obtaining the Institutional Ethical Clearance, the study was conducted. Forty patients of American Society of Anesthesiologists Class I and II were enrolled in this randomized study. The patients were randomly divided into two groups; group normal saline (NS) and group dexmedetomidine. Patient received either NS or dexmedetomidine in group NS and group dexmedetomidine, respectively, depending upon the allocation. The infusion rate was adjusted according to; loading dose (1 μg/kg) over 10 min and maintenance dose (0.5 μg/kg/h) and perioperative hemodynamics was recorded. Routine general anesthesia was administered in all the patients with conventional technique without deviating from institutional protocols. Postoperatively, Rasmsay sedation score, time taken for request of first analgesic dose, and side effects if any were recorded.
The categorical factors are represented by the number and frequency (%) of cases. The continuous variables are represented by measures of central frequency and standard deviation. The statistical analysis was done by using unpaired -test and Chi-square. < 0.05 was considered statistically significant.
Significant hemodynamic changes are observed in NS group during laryngoscopy, intubation, during pneumoperitoneum formation, and during extubation. Hemodynamic stress response in dexmedetomidine group was significantly attenuated. Analgesic requirement during postoperative 24 h were much less in dexmedetomidine group when compared to NS group. No significant side effects were noted except for bradycardia; which was observed in two cases of dexmedetomidine group.
Dexmedetomidine infusion in the dose of 1 μg/kg body weight as bolus over 10 min and 0.5 μg/kg/h intraoperatively as maintenance dose controlled the hemodynamic stress response in patients undergoing laparoscopic surgery. Use of dexmedetomidine extends the pain free period postoperatively and thereby reducing total analgesic requirement. Thus, dexmedetomidine can be utilized as an ideal anesthetic adjuvant during laparoscopic surgeries.
与开放手术相比,腹腔镜手术因具有多种优势而使用量呈上升趋势。主要优势在于切口小,在美观上可以接受,并且现在大多数都是日间手术。腹腔镜手术克服了经济负担和医院床位占用的问题。然而,所有这些优势并非没有缺点,因为术中常见诸如高血压、心动过速等血流动力学变化以及其他与手术相关的并发症。右美托咪定是一种α激动剂药物,作用于脊髓上和脊髓水平,调节中枢神经系统中伤害性信号的传递。右美托咪定对心血管系统的基本作用是降低心率和全身血管阻力,并具有额外的阿片类药物节省效应。这种药物已成为全身麻醉期间的理想辅助药物,尤其是在预期有应激反应时。因此,该药物在腹腔镜手术中进行了研究。
(a)研究右美托咪定对腹腔镜手术患者围手术期血流动力学参数的影响。(b)研究术后镇静评分和镇痛需求。(c)研究右美托咪定的副作用情况。
随机双盲对照试验。
获得机构伦理批准后开展本研究。40例美国麻醉医师协会分级为I级和II级的患者纳入本随机研究。患者被随机分为两组;生理盐水组(NS组)和右美托咪定组。根据分组情况,NS组患者接受生理盐水,右美托咪定组患者接受右美托咪定。输注速率根据以下调整;10分钟内给予负荷剂量(1μg/kg),维持剂量(0.5μg/kg/h),并记录围手术期血流动力学情况。所有患者均采用常规技术进行常规全身麻醉,不偏离机构方案。术后,记录Ramsay镇静评分、首次要求给予镇痛剂量的时间以及是否有副作用。
分类因素用病例数和频率(%)表示。连续变量用中心频率和标准差表示。采用非配对t检验和卡方检验进行统计分析。P<0.05被认为具有统计学意义。
NS组在喉镜检查、插管、气腹形成和拔管期间观察到显著的血流动力学变化。右美托咪定组的血流动力学应激反应明显减弱。与NS组相比,右美托咪定组术后24小时内的镇痛需求要少得多。除了心动过缓外未观察到明显副作用;右美托咪定组有2例出现心动过缓。
以1μg/kg体重的剂量在10分钟内静脉推注右美托咪定,并在术中以0.5μg/kg/h作为维持剂量输注,可控制腹腔镜手术患者的血流动力学应激反应。使用右美托咪定可延长术后无痛期,从而减少总镇痛需求。因此,右美托咪定可作为腹腔镜手术期间的理想麻醉辅助药物。